Plain-English translation of NCT07363590 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage study of a new medication called designed to treat lupus and rheumatoid arthritis. Researchers want to understand how safe this medication is and how well people tolerate it at different dose levels. The study will help doctors learn if this treatment could help people with these autoimmune conditions.
Lupus and rheumatoid arthritis are serious conditions where the immune system attacks the body's own tissues. This study exists to find new treatment options and to make sure any new medication is safe before it can be offered to patients more widely.
You likely qualify if…
You likely don't qualify if…
Depending on which part of the study you join, you would receive the medication through an IV (intravenous) injection. Some participants will receive a single dose, while others will receive three doses given over a 3-week period. You will be monitored closely for safety and side effects throughout the study, with blood tests and check-ins to see how your body responds to the treatment.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Australia
Belgium
China